Author Correction: T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
Stephan, Matthias. T, Ponomarev, Vladimir, Brentjens, Renier .J, Chang, Alex. H, Dobrenkov, Konstantin. V, Heller, Glenn, Sadelain, Michel
Published in Nature medicine (01.06.2024)
Published in Nature medicine (01.06.2024)
Get full text
Journal Article
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
Sadelain, Michel, Stephan, Matthias T, Ponomarev, Vladimir, Brentjens, Renier J, Chang, Alex H, Dobrenkov, Konstantin V, Heller, Glenn
Published in Nature medicine (01.12.2007)
Published in Nature medicine (01.12.2007)
Get full text
Journal Article
Introducing a new reporter gene, membrane-anchored Cypridina luciferase, for multiplex bioluminescence imaging
Moroz, Maxim A., Zurita, Juan, Moroz, Anna, Nikolov, Ekaterina, Likar, Yury, Dobrenkov, Konstantin, Lee, Jason, Shenker, Larissa, Blasberg, Ronald, Serganova, Inna, Ponomarev, Vladimir
Published in Molecular therapy. Oncolytics (25.06.2021)
Published in Molecular therapy. Oncolytics (25.06.2021)
Get full text
Journal Article
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy
Guelen, Lars, Fischmann, Thierry O, Wong, Jerelyn, Mauze, Smita, Guadagnoli, Marco, Bąbała, Nikolina, Wagenaars, Jozef, Juan, Veronica, Rosen, David, Prosise, Winnie, Habraken, Maurice, Lodewijks, Imke, Gu, Danling, Stammen-Vogelzangs, Judith, Yu, Ying, Baker, Jeanne, Lutje Hulsik, David, Driessen-Engels, Lilian, Malashock, Dan, Kreijtz, Joost, Bertens, Astrid, de Vries, Evert, Bovens, Astrid, Bramer, Arne, Zhang, Yiwei, Wnek, Richard, Troth, Sean, Chartash, Elliot, Dobrenkov, Konstantin, Sadekova, Svetlana, van Elsas, Andrea, Cheung, Jason K, Fayadat-Dilman, Laurence, Borst, Jannie, Beebe, Amy M, Van Eenennaam, Hans
Published in Journal for immunotherapy of cancer (01.09.2022)
Published in Journal for immunotherapy of cancer (01.09.2022)
Get full text
Journal Article
First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
Geva, Ravit, Voskoboynik, Mark, Dobrenkov, Konstantin, Mayawala, Kapil, Gwo, Jennifer, Wnek, Richard, Chartash, Elliot, Long, Georgina V.
Published in Cancer (15.11.2020)
Published in Cancer (15.11.2020)
Get full text
Journal Article
Solid tumors in young children in Moscow Region of Russian Federation
Kachanov, Denis, Dobrenkov, Konstantin, Shamanskaya, Tatyana, Abdullaev, Ruslan, Inushkina, Evgueniya, Savkova, Rimma, Varfolomeeva, Svetlana, Rumyantsev, Alexander
Published in Radiology and oncology (01.03.2008)
Published in Radiology and oncology (01.03.2008)
Get full text
Journal Article
Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors
Papadopoulos, Kyriakos P, Autio, Karen, Golan, Talia, Dobrenkov, Konstantin, Chartash, Elliot, Chen, Qiusheng, Wnek, Richard, Long, Georgina V
Published in Clinical cancer research (01.04.2021)
Published in Clinical cancer research (01.04.2021)
Get full text
Journal Article
Tumor-draining Lymph Nodes of Primary Lung Cancer Patients: A Potent Source of Tumor-specific Killer Cells and Dendritic Cells
KIMURA, Hideki, DOBRENKOV, Konstantin, IIDA, Tomohiko, SUZUKI, Makoto, ANDO, Sohichiro, YAMAMOTO, Naotaka
Published in Anticancer research (01.01.2005)
Get full text
Published in Anticancer research (01.01.2005)
Journal Article
Phase I Study of MK-4166, an Anti-Human Glucocorticoid-Induced Tumor Necrosis Factor Receptor Antibody, Alone or With Pembrolizumab in Advanced Solid Tumors
Papadopoulos, Kyriakos P., Autio, Karen, Golan, Talia, Dobrenkov, Konstantin, Chartash, Elliot, Chen, Qiusheng, Wnek, Richard, Long, Georgina V.
Published in Clinical cancer research (21.12.2020)
Published in Clinical cancer research (21.12.2020)
Get full text
Journal Article
Phase 1 trial of the anti-LAG3 antibody favezelimab plus pembrolizumab in advanced gastric cancer
Rha, Sun Young, Miller, Wilson H., de Miguel, María José, Im, Seock-Ah, Lugowska, Iwona, Wermke, Martin, Kotani, Daisuke, Bauer, Todd Michael, Takashima, Atsuo, Palcza, John, Chaney, Marya F., Dobrenkov, Konstantin, Garralda, Elena
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
First-in-human phase 1 study of MK-1248, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody, as monotherapy or in combination with pembrolizumab in patients with advanced solid tumors
Geva, Ravit, Voskoboynik, Mark, Beebe, Amy M, Gwo, Jennifer, Dobrenkov, Konstantin, Chartash, Elliot, Long, Georgina V.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase 1 study of MK-4166, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) antibody, as monotherapy or with pembrolizumab (pembro) in patients (pts) with advanced solid tumors
Papadopoulos, Kyriakos P., Autio, Karen A., Golan, Talia, Dobrenkov, Konstantin, Chartash, Elliot, Li, Xiaoyun Nicole, Wnek, Richard, Long, Georgina V.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Monitoring the Efficacy of Adoptively Transferred Prostate Cancer-Targeted Human T Lymphocytes with PET and Bioluminescence Imaging
Dobrenkov, Konstantin, Olszewska, Malgorzata, Likar, Yury, Shenker, Larissa, Gunset, Gertrude, Cai, Shangde, Pillarsetty, Nagavarakishore, Hricak, Hedvig, Sadelain, Michel, Ponomarev, Vladimir
Published in Journal of Nuclear Medicine (01.07.2008)
Published in Journal of Nuclear Medicine (01.07.2008)
Get full text
Journal Article
A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs
Likar, Yury, Zurita, Juan, Dobrenkov, Konstantin, Shenker, Larissa, Cai, Shangde, Neschadim, Anton, Medin, Jeffrey A, Sadelain, Michel, Hricak, Hedvig, Ponomarev, Vladimir
Published in Journal of Nuclear Medicine (01.09.2010)
Published in Journal of Nuclear Medicine (01.09.2010)
Get full text
Journal Article
Abstract CT095: Phase 1 evaluation of triple therapy with boserolimab (anti-CD27 agonist), pembrolizumab, and chemotherapy in patients with triple-negative breast cancer (TNBC) with PD-L1 combined positive score (CPS) <10: Safety, antitumor activity, and association between biomarkers and response
Rojas, Carlos, de Spéville, Bernard Gaston Doger, Im, Seock-Ah, Shapira-Frommer, Ronnie, De Miguel, María, Cortijo, Lucía González, Marin, Margarita Romeo, de Jonge, Maja, Ayers, Mark, Zhang, Yiwei, Zhai, Song, Chartash, Elliot, Dobrenkov, Konstantin, Sohn, Joohyuk
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article